Development and characterization of a novel microtissue-based 3D human liver fibrosis model for anti-fibrotic drug discovery

被引：0
|
作者：
Kostadinova, R. [1 ]
Neelakandhan, A. [1 ]
Kijanska, M. [1 ]
Zapiorkowska, N. [1 ]
Steiert, S. [1 ]
Guye, P. [1 ]
Messner, S. [1 ]
机构：
[1] InSphero AG, Schlieren, Switzerland
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30333-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PS-103
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [21] Evaluation of dioxin induced transcriptomic responses in a 3D human liver microtissue model
    Yan, Lu
    Messner, Catherine Jane
    Tian, Mingming
    Gou, Xiao
    Suter-Dick, Laura
    Zhang, Xiaowei
    ENVIRONMENTAL RESEARCH, 2022, 210
  • [22] In vitro inhibition and induction of human liver cytochrome P450 enzymes by a novel anti-fibrotic drug fluorofenidone
    Li, Linling
    Luo, Xi
    Cheng, Zeneng
    XENOBIOTICA, 2021, 51 (07) : 745 - 751
  • [23] Development and characterization of a 3D multicell microtissue culture model of airway smooth muscle
    West, Adrian R.
    Zaman, Nishat
    Cole, Darren J.
    Walker, Matthew J.
    Legant, Wesley R.
    Boudou, Thomas
    Chen, Christopher S.
    Favreau, John T.
    Gaudette, Glenn R.
    Cowley, Elizabeth A.
    Maksym, Geoffrey N.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2013, 304 (01) : L4 - L16
  • [24] Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model
    Kostadinova, Radina
    Strobel, Simon
    Chen, Li
    Fiaschetti-Egli, Katia
    Gadient, Jana
    Pawlowska, Agnieszka Pawlowska
    Petitjean, Louis
    Bieri, Manuela
    Thoma, Eva
    Petitjean, Mathieu
    JOURNAL OF HEPATOLOGY, 2024, 80 : S590 - S590
  • [25] DEVELOPMENT AN IN VITRO MODEL CULTURE FOR TESTING OF ANTI-FIBROTIC DRUGS USING HUMAN PRECISION CUT LIVER SLICES
    Aoudjehane, L.
    Legrand, M.
    Perdigao, F.
    Scatton, O.
    Becquart, J.
    Housset, C.
    Calmus, Y.
    Conti, F.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S710 - S710
  • [26] Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model
    Kostadinova, Radina
    Stroebel, Simon
    Chen, Li
    Fiaschetti-Egli, Katia
    Gadient, Jana
    Pawlowska, Agnieszka
    Petitjean, Louis
    Bieri, Manuela
    Thoma, Eva
    Petitjean, Mathieu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] THE NCU-G1gt/gt MOUSE AS A LIVER FIBROSIS MODEL ORGANISM: A STUDY OF THE DEVELOPMENT OF FIBROSIS AND RESPONSE TO ANTI-FIBROTIC TREATMENT
    Schjalm, C.
    Kong, X. Y.
    Kaasi, C.
    Eskild, W.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S461 - S462
  • [28] Anti-fibrotic Effects of AR-13324 in a 3D Bioengineered Human Trabecular Meshwork Model of Steroid-induced Glaucoma
    Kopczynski, Casey
    Ahmed, Feryan
    Bharali, Dhruba
    Torrejon, Karen
    Lin, Cheng-Wen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [29] Applying a microphysiological 3D human liver-islet microtissue platform to study drug-drug interaction
    Hoelting, L.
    Karakoc, I.
    Rufer, C.
    Moritz, W.
    Yesildag, B.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 187 - 187
  • [30] FT-011, a novel anti-fibrotic drug, reduced cardiac fibrosis and improved cardiac function in an experiemental model of myocardial infarction
    Elsik, M.
    Zhang, Y.
    Wang, B.
    Adrahtas, A.
    Gilbert, R.
    Krum, H.
    Kelly, D.
    EUROPEAN HEART JOURNAL, 2007, 28 : 46 - 46
12345